Pulmonx Corp (LUNG) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $69.75M | -1.6% |
| 2024 | $70.91M | -15.1% |
| 2023 | $83.55M | -17.9% |
| 2022 | $101.74M | -31.5% |
| 2021 | $148.48M | -35.9% |
| 2020 | $231.56M | +1468.1% |
| 2019 | $14.77M | +258.1% |
| 2018 | $4.12M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $69.75M | -1.6% |
| 2024 | $70.91M | -15.1% |
| 2023 | $83.55M | -17.9% |
| 2022 | $101.74M | -31.5% |
| 2021 | $148.48M | -35.9% |
| 2020 | $231.56M | +1468.1% |
| 2019 | $14.77M | +258.1% |
| 2018 | $4.12M | — |